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Introduction. Cutaneous tuberculosis as a result of a needle injection is a rare event; it generally occurs 
among medical and laboratory personnel and among patients receiving percutaneous treatment.
Objective. Six patients are presented who developed cutaneous tuberculosis after mesotherapy 
cosmetic treatment.
Material and methods. One to four months after injection of an unknown product as treatment for 
obesity and cellulites, five women and a man developed papules, nodules and drainage of wax like 
material at the inoculated sites; this was interpreted clinically as a non tuberculous mycobacterium 
infection. Skin biopsies were taken for a histopathologic study; the biopsy and exudates were cultured 
to make a phenotypic identification. Polymerase chain reaction and restriction enzyme pattern analyses 
(PCR-restriction pattern analysis)) procedures were applied to the skin biopsies.
Results. Mycobacterium tuberculosis was confirmed in the culture and by PRA analysis in the paraffin-
embedded biopsies. The patients had never had tuberculosis. Their thoracic X rays were normal and 
the size of the tuberculin reaction was 17 to 20 mm. Five patients recovered with antituberculosis 
treatment and the sixth spontaneously healed after the removal of the largest cutaneous module. No 
satellite adenopathy or recurrences were observed. 
Conclusions. A previously undescribed mode of acquisition cutaneous tuberculosis was described. 
This was the second incident of a demonstrated cutaneous tuberculosis following mesotherapy in 
Colombia. Skin lesions induced by injections must be tested to detect mycobacterias to include M. 
tuberculosis.
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Tuberculosis cutánea por mesoterapia, estudio de seis casos 
Introducción. La tuberculosis cutánea secundaria a la inyección con agujas es rara; se presenta en 
personal médico y de laboratorio, y en pacientes que reciben tratamientos percutáneos.
Objetivo. Presentar seis pacientes con tuberculosis cutánea secundaria a tratamiento por 
mesoterapia.
Materiales y métodos. Entre 1 y 4 meses después de la inyección en la piel glútea y abdominal de 
material no precisado, como tratamiento para la obesidad y la celulitis, cinco mujeres y un hombre 
desarrollaron pápulas, nódulos y senos de drenaje de material seroso en los sitios de inoculación, 
interpretados clínicamente como infección por micobacterias no tuberculosas. 
Se practicaron cultivos de las secreciones y de las biopsias de piel para la identificación fenotípica 
y estudio de histopatología. Con los resultados iniciales se realizaron pruebas moleculares de PRA 
(PCR-restriction pattern analysis) en las biopsias de piel y estudio ampliado de los pacientes.
Resultados. Se demostró Mycobacterium tuberculosis en los cultivos, hallazgo confirmado por la 
técnica de PRA en las biopsias incluidas en parafina. Los pacientes no habían padecido tuberculosis. 
Las placas de tórax fueron normales y la tuberculina midió entre 17 y 20 mm. Cinco curaron con terapia 
antituberculosa y otro curó espontáneamente luego de la resección-biopsia de la lesión más grande. 
No se encontraron adenopatías satélites ni recurrencias.
Conclusiones. Se demostró una nueva forma de adquirir la tuberculosis cutánea. Esta es la segunda 
demostración de tuberculosis cutánea por mesoterapia en Colombia. El estudio de las lesiones de la 
piel en el sitio de la inyección cutánea debe incluir pruebas para detectar micobacterias, entre ellas M. 
tuberculosis. Las autoridades sanitarias deben prestar atención y prevenir esta modalidad de adquirir 
la tuberculosis.
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Mesotherapy or intradermotherapy is a mode of 
treatment established since the 1950s. The 
treatment consists of injecting several medications 
in the middle dermis and are mixed with local 
anesthetics such as procaine mesocaine or 
lydocaine.  This blend reaches a high and persistent 
concentration to permit a prolonged activity of up 
to five days duration (1). This method has proved 
useful in areas such as pain reduction, traumatology, 
orthopedics, physiatrist and rheumatology (1). 
However, cutaneous injections, applied by medical 
doctors or lay people, can cause important 
complications such as atypical mycobacteria or 
nontuberculosis mycobacteria (NTM) infections. 
The infections are recognizeable because of lesion 
frequency, profusion and size (2-7).
The current report presents six patients who were 
subjected to cosmetic mesotherapy treatment and 
subsequently developed papules and cutaneous 
nodules, at first diagnosed as caused by NTM. 
Further culture and molecular analysis showed the 
causal agent to be Mycobacterium tuberculosis.
Patients
Case 1. Seventy year old woman. Four months 
after receiving injections in abdominal skin as a 
mesotherapy treatment for grooves, large nodules 
appeared on her lower abdomen; ulcerated 
erythematous plaques with a slight secretion were 
present at the injection sites. The patient was 
unsuccessfully treated with multiple antibiotics. 
Biopsies were performed in the ulcerated plaques 
to provide tissue for histopathologic examination 
and to culture for the presence of NTM.  On the 
fourth week of culture incubation, bacterial growth 
was observed and identified as M. tuberculosis.
Case 2. Forty-three year old woman. Four months 
after mesotherapy treatment for grooves and 
abdominal and thigh cellulite depositions, the 
patient developed nodules and abscesses at 
the injected sites; the condition was diagnosed 
as caused by NTM.  A biopsy for culture and 
histopathologic analysis was performed. On the 
eight week of culture incubation, bacterial growth 
occurred that was identified as M. tuberculosis 
through phenotypical and genotypical tests.
Case 3. A fifty-five year old male developed 
edematous cutaneous papules and nodules on 
the abdominal skin three months after receiving 
mesotherapy treatment for abdominal adipose. 
His wife also developed similar lesions after 
mesotherapy treatment (Case 6). A biopsy for 
cultural and histopathologic identification of the 
causative agent was performed; a culture of 
the nodule secretions was also taken. Bacterial 
growth occurred at the ninth week of incubation 
and was later identified as M. tuberculosis through 
phenotypical and genotypical tests.
Case 4. Fifty year old woman. The patient was 
subjected to local injections on abdominal, buttocks 
and thighs to eliminate grooves and cellulite. A 
month later, she developed erythematous papules 
and nodules of slow growth on thighs and abdomen-
-some of them ulcerated with serous bloodshot 
secretions. A lesion was excised and diagnosed as 
non specific inflammation. Because the ulceration 
and secretion persisted in the remaining lesions, 
the patient consulted a dermatologist, who ordered 
cultures for NTM. On the fourth week, the cutaneous 
lesion culture was positive for M. tuberculosis 
through phenotypical and genotypical tests. The 
patient refused antibiotic treatment for tuberculosis 
but healed spontaneously of the papules six 
months later. Depressed and hyperpigmented 
scars remained at the sites of the papules.
Case 5. Forty seven year old woman. During the 
previous six months, the patient presented hard, 
painful nodules and placques on abdomen, back 
and thighs that spontaneously drained pus 
(Figure 1). They began to develop four months after 
receiving local injections to lose weight. She was 
treated with local triamcinolone infiltrations without 
success. A biopsy was performed on one of the 
lesions for culture and histopathological analysis. 
On the sixth week of incubation, the culture was 
positive for M. tuberculosis through phenotypical 
and genotypical tests.
Case 6. Forty three year old woman, wife of case 3. 
Three months after receiving injection in abdomen 
skin to reduce obesity, the patient developed 
several erythematous nodules and papules; 
several were ulcerated and draining. Skin biopsy 
was performed in one lesion for culture, and on 
another for histopathological analysis to confirm 
NTM abscesses. The culture did not have bacterial 
growth after 16 weeks of incubation. Molecular 
tests demonstrated the presence of M. tuberculosis 
DNA in the skin biopsy.
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Genotypic identification
Mycobacterium genomic DNA extraction. Samples 
were initially treated with 5% Chelex-100 (Sigma) 
and then subjected to a standard analysis protocol 
was followed (10,11).
Molecular identification. The identifications were 
performed on skin biopsies embedded in paraffin 
from five patients at the Laboratory of Mycobacteria 
on request of the Laboratory of Pathology, both 
laboratories at the Colombian National Institute of 
Health in Bogotá. In the Laboratory of Pathology, 
the case biopsies had been processed for 
histopathological study over a three-year period 
before submission to the Laboratory of Mycobacteria. 
At the Laboratory of Mycobacteria, techniques of 
restriction pattern analysis (PRA) were used to 
identify mycobacteria following standard protocols 
(12). Mycobacterium tuberculosis H37Rv was used 
as positive control and sterile water as negative 
control. The restriction patterns were analyzed 
using this net site (http://app.chuv.ch/prasite/index.
html).
Additional study of the patients
Once M. tuberculosis was identified, the attending 
physicians were informed. The physicians then 
acquired additional information from their patients 
that included past or present family history of 
tuberculosis, thoracic X-rays and tuberculin 
reaction. Five of the patients received standard 
treatment established for tuberculosis.
Results
Direct ZN staining. It was negative in all samples 
tested.
Phenotypical Identification. In five of the six 
cases, positive cultures at 37°C were obtained for 
M. tuberculosis within a period ranging from 4 to 9 
weeks (table 1). Colonies had a wrinkled, dry aspect, 
without pigment, and corresponded to acid alcohol-
resistant bacilli as indicated by the ZN staining. 
Biochemical and enzymatic tests of culture were 
niacin- and catalase-positive at room temperature, 
catalase-negative at 68°C and positive for nitrate 
reduction. These tests showed that the isolated 
bacterial species were M. tuberculosis.
Susceptibility tests. The case 5 isolate showed 
resistance to isoniacide. The other isolates were 
sensitive to the antimicrobial drugs studied.
Molecular identification through PRA. The 
same PRA restriction pattern was present in the 
Materials and methods
Samples. Secretion samples from lesions and skin 
biopsies were taken from the six patients who were 
remitted to the laboratory between October 2004 
and December 2005. Each sample was subjected to 
direct tests and culture. Five patients had biopsies 
for histopathological analysis, consisting in 4x5 
mm skin cylinders fixed in neutral formaldehyde, 
paraffin-embedded, and stained with hematoxylin-
eosin and Ziehl-Neelsen (ZN).
Phenotypical identification and susceptibility 
tests to drugs. After decontamination, samples 
were placed in culture media (Ogawa Kudoh and 
Stonebrink), at 32°C and 37°C. Recovered isolates 
were colored with ZN stain and subjected to 
biochemical and enzymatic tests for mycobacteria 
identification (8). Susceptibility to isoniacide, 
rifampicine, ethambutol and streptomycin was 
determined by standard methods (9). 
Figure 1. Eritematous papules and placques with crusty surface 
(A) and (B).
A
B
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five samples and characteristic of Mycobacterium 
species of the M. tuberculosis complex.
Histopathology. Skin biopsies showed similar 
lesion structure, located predominantly within 
the deep dermis and on the hypodermis (figure 
2). Granulomatous inflammation with abundant 
epithelioid cells was present, along with a number 
of Langhans giant cells, numerous lymphocytes, a 
few plasma cells, and vacuolated macrophages. 
Many polymorphonuclear leucocytes were seen, 
either dispersed or forming abscesses, at the center 
of some granulomas or surrounding small vacuoles. 
Small areas of fibrinoid necrosis was observed at 
the center of some granulomas. The lesions were 
typically deep into the adipose lobules. Only in Case 
five were acid fast bacilli found to be phagocytized 
in few macrophages (figure 2C). The image did not 
suggest tuberculosis but inflammation by NTM, a 
conclusion based on prior experience with NTM 
inflammations (13).
Additional study of the patients. None of the 
six patients had an underlying disease or had 
tuberculosis, nor was a history of tuberculosis 
noted their families. Tuberculin tests were 
strongly positive in five of patients, and ranged 
from 17 to 20 mm in diameter. For five patients, 
the thoracic X rays were normal; no information 
was available for the sixth patient. None had 
developed satellite adenopathies. Five were cured 
with strictly supervised antituberculosis treatment, 
and one patient was cured of four lesions without 
antituberculosis treatment. None of the patients 
had presented recurrence of lesions after more 
than one year of follow up.
Discussion
Lesions appeared in patients a few months after 
mesotherapy and were limited to the injection 
site. They were in the form of multiple non painful 
erythematous papules and nodules, some of them 
ulcerated and draining, without satellite adenopathy. 
The lesions were diagnosed as caused by NTM 
upon consultation with dermatologists and after 
several failing treatments. After culture of lesions 
and skin biopsies, the expected NTM, such as M. 
abscessus, M. chelonae or M fortuitum (2-7) were 
not isolated. Instead M. tuberculosis was identified 
by its phenotype in culture. Therefore,molecular 
methods were employed to confirm the presence of 
M. tuberculosis. The PRA test of the skin biopsies 
embedded in paraffin confirmed that they contained 
DNA of M. tuberculosis. This test further confirmed 
that the isolated M. tuberculosis is not a laboratory 
contaminantt (14). Isolates were obtained without 
difficulty, with defined colonies, and in different 
periods of time; this provided additional evidence 
that sample contamination was not a factor (14). All 
the phenotypical and genotypical evidence pointed 
to M. tuberculosis as the correct identification.
Only one of the isolated bacilli was isoniacide-
resistant. The tuberculosis-specific treatment was 
successful in five of the six patients, who, 
nevertheless, were left with noticeable, hyper 
pigmented, depressed scars. One patient (Case 4), 
healed spontaneously after the largest nodule was 
removed. These cases of cutaneous tuberculosis 
occurred in healthy persons which were treated 
with mesotherapy for esthetic reasons. Because 
the tuberculosis was localized at the lesion site, 
immunity probably developed due to previous 
exposure to the bacilli. Prior immunity may have 
permitted the spontaneous cure in one of the 
tuberculosis cases. Some level of immunity may be 
expected in older people whose lifetime has been 
spent a in tuberculosis-endemic country.
This is a new inoculation form of M. tuberculosis. 
Only one other case had been reported, also 
in Colombia (15). The origin of these bacteria is, 
at present, speculative.  They probably were not 
present in the injected product, noting that the 
composition of these products is not publically 
available (15). If the product were contaminated 
with M. tuberculosis, the number of infected 
patients will be greater. If the product were 
contaminated with NTM due to poor hygienic 
practices such as non-sterile needles, syringes, or 
distilled water, the introduction of the NTM in the 
product flask will have resulted in its distribution to 
a larger patient population (2,5-7,13).  Local health 
authorities have been informed of these cases by 
the Colombia National Institute of Health, as these 
officials are responsible for further investigations of 
the conditions under which the mesotherapy was 
performed.. Another source of infection may be the 
person that performs the injections; this possibillity 
was not investigated.
Cutaneous tuberculosis inoculation through injection 
is a rare event, first reported in in the 1950s, 
and only occasionally more recently (16,17). 
It has been shown in patients that received 
corticosteroid intramuscular injections (18), in 
children vaccinated against pertussis -where both 
nurse and physician had pulmonary tuberculosis 
(19), and in medical doctors, nurses and laboratory 
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personnel injured by needles contaminated with 
blood or tissues from tuberculosis or AIDS patients 
(20-22). Cutaneous inoculation with tuberculosis 
in people without previous contact with the bacilli 
(usually children), a primary tuberculosis occurs, 
with satellite adenopathy (23,24). Possibly, the 
injection site becomes a locus minoris resistentiae, 
where the tuberculosis bacilli have better growing 
conditions (25). The most recent form of cutaneous 
tuberculosis through inoculation was associated 
with neural therapy (15) or mesotherapy, such as 
the patients introduced herein.
Nonetheless, skin lesions that appear at 
injection sites following therapeutic or cosmetic 
interventions (17,26) must be examined by culture 
for Mycobacterium and other microorganisms and 
cannot be treated as a common bacterial infection. 
Occasionally, these examinations demonstrate that 
the cutaneous lesions are sterile, even though they 
have clinical and histopathological features similar 
to those reported here (27).
In conclusion, mesotherapy is a widely used 
cosmetic treatment administered through injections 
on abdomen, buttocks and face.  These can 
produce complications caused by NTM that consist 
of deep tissue cutaneous papules and nodules 
that drain to the skin surface and which, after 
healing, leave noticeable scarring (2-7). In the 
current case report, similar lesions were produced 
by M. tuberculosis, as identified by phenotypical 
and genotypical methods. When cutaneous 
lesions occur on intradermotherapy injection sites, 
inflammation caused by mycobacteria is suspect. 
Culture of the skin biopsy or secretion is essential 
to identify causal agents, however. Antibiotic 
treatment has proved to be effective. Information 
concerning these complications is recommended for 
distribution among personnel performing this kind 
of intervention and recipient patients.  The current 
study further recommends that health authorities 
schedule periodic  inspections of the protocols 
used in mesotherapeutic clinics, including strict 
biosecurity regulation, drug usage and stringent 
asepsis of implements,
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Figura 2. Panoramic view of granulomatous septal and lobular 
hypodermitis (A), with tuberculoid granulomas (B), and scant 
bacilli phagocytosed by a macrophage (C). A: hematoxylin-
eosin, 4X; B: hematoxylin-eosin, 16X; C: Ziehl-Neelsen, 100X.
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